JUPITER ASSET MANAGEMENT LTD

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1215838 London, X0

Position in AUPH

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$18,573,240

+$6,666,572 QoQ

Shares Held

1,094,475

+36.2% QoQ

Ownership

0.823%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#15

of 279 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JUPITER ASSET MANAGEMENT LTD holds $354,007,590 across 28 Biotechnology names. AUPH ranks #6 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	126,099	$78,627,770
2	INCY	Incyte Corp	511,050	$57,932,627
3	PTCT	Ptc Therapeutics, Inc.	707,450	$57,706,695
4	NTLA	Intellia Therapeutics, Inc.	1,849,507	$31,293,657
5	IOVA	Iovance Biotherapeutics, Inc.	4,535,080	$18,865,932
6	AUPH	Aurinia Pharmaceuticals Inc. This page	1,094,475	$18,573,240
7	BEAM	Beam Therapeutics Inc.	445,718	$15,297,041
8	RLAY	Relay Therapeutics, Inc.	719,576	$13,463,266

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,573,240	1,094,475	+36.2%	Shares	Defined	2026-08-10
2026-03-31	$11,906,668	803,419	-10.7%	Shares	Defined	2026-05-12
2025-12-31	$14,346,753	899,483	+9.2%	Shares	Defined	2026-02-10
2025-09-30	$9,100,547	823,579	-11.8%	Shares	Defined	2025-11-10
2025-06-30	$7,909,810	933,862	+24.1%	Shares	Defined	2025-08-08
2025-03-31	$6,052,262	752,769	+374.9%	Shares	Sole	2025-05-09
2024-06-30	$905,017	158,497	-35.8%	Shares	Defined	2024-08-08
2024-03-31	$1,237,730	247,052	+21.3%	Shares	Defined	2024-05-10
2023-12-31	$1,831,137	203,686	+551.3%	Shares	Defined	2024-02-09
2023-09-30	$243,006	31,275	-68.3%	Shares	Defined	2023-11-09
2023-06-30	$955,319	98,690	—	Shares	Defined	2023-08-10
No filing history on record for this holder in this stock.